We are live on ! Find out more
TNYA icon

Tenaya Therapeutics
TNYA

79 hedge funds and large institutions have $280M invested in Tenaya Therapeutics in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

687% more call options, than puts

Call options by funds: $732K | Put options by funds: $93K

250% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 6

218% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 11

118% more capital invested

Capital invested by funds: $128M → $280M (+$151M)

23% more funds holding

Funds holding: 64 → 79 (+15)

3.99% more ownership

Funds ownership: 67.28% → 71.26% (+4%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
79
Holders Change
+15
Holders Change %
+23.44%
% of All Funds
1.24%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
21
Increased
35
Reduced
11
Closed
6
Calls
$732K
Puts
$93K
Net Calls
+$639K
Net Calls Change
+$793K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.94M
2
LGM
Logos Global Management
California
+$3.49M
3
Invesco
Invesco
Georgia
+$2.73M
4
State Street
State Street
Massachusetts
+$1.89M
5
CC
Casdin Capital
New York
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
ROTUOC
Regents of the University of California
California
-$5.49M
2
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$1.7M
3
Renaissance Technologies
Renaissance Technologies
New York
-$994K
4
Citadel Advisors
Citadel Advisors
Florida
-$488K
5
Bank of America
Bank of America
North Carolina
-$155K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
1
Column Group
California
$55.2M – – –
CC
2
Casdin Capital
New York
$37.5M +$1.76M +302,517 +5%
RCM
3
RA Capital Management
Massachusetts
$35.6M – – –
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$26.2M +$482K +82,858 +2%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$22M -$35.2K -6,057 -0.2%
BlackRock
6
BlackRock
New York
$21.3M +$4.94M +850,661 +31%
Vanguard Group
7
Vanguard Group
Pennsylvania
$11.7M +$766K +131,752 +7%
T. Rowe Price Investment Management
8
T. Rowe Price Investment Management
Maryland
$7.47M -$1.7M -292,333 -19%
Citadel Advisors
9
Citadel Advisors
Florida
$5.96M -$488K -84,022 -8%
AI
10
Alphabet Inc
California
$5.38M – – –
EC
11
Euclidean Capital
New York
$5.38M – – –
State Street
12
State Street
Massachusetts
$4.83M +$1.89M +325,398 +65%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$4.81M +$167K +28,782 +4%
HMC
14
Harvard Management Company
Massachusetts
$3.95M – – –
LGM
15
Logos Global Management
California
$3.52M +$3.49M +600,000 New
Invesco
16
Invesco
Georgia
$2.76M +$2.73M +469,753 New
SG
17
StepStone Group
California
$2.71M – – –
Northern Trust
18
Northern Trust
Illinois
$2.45M +$405K +69,664 +20%
Millennium Management
19
Millennium Management
New York
$1.98M +$1.03M +177,201 +110%
TOCUITCONY
20
Trustees of Columbia University in the City of New York
New York
$1.71M – – –
Two Sigma Investments
21
Two Sigma Investments
New York
$1.42M +$720K +123,876 +104%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.18M +$425K +73,174 +57%
BCM
23
Bridgeway Capital Management
Texas
$1.07M – – –
N
24
Nuveen
North Carolina
$941K +$498K +85,766 +115%
GCP
25
GSA Capital Partners
United Kingdom
$724K +$205K +35,243 +40%
1
2 3 4

TNYA Hedge Fund Activity: Q2 2023 in Review

79 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q2 2023, worth a combined $280M — up 118% from $128M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new TNYA positions and 6 closed out — a net gain of 15 holders — while 35 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $4.94M. The largest seller was Regents of the University of California, cutting an estimated $5.49M.

  • 79 institutional investors held Tenaya Therapeutics (TNYA) as of Q2 2023, up from 64 in Q1 2023.
  • Funds reported $280M of Tenaya Therapeutics stock for Q2 2023, up 118% quarter-over-quarter.
  • 21 funds opened new Tenaya Therapeutics positions in Q2 2023 and 6 closed out, a net change of +15 holders.
  • The largest Tenaya Therapeutics buyer in Q2 2023 was BlackRock, an estimated $4.94M added.
  • The largest Tenaya Therapeutics seller in Q2 2023 was Regents of the University of California, an estimated $5.49M sold.

Based on aggregated 13F filings for Q2 2023.